Gilead Sciences fails to expand promised access to lifesaving drug for people living with HIV
Inaction by US pharmaceutical corporation Gilead to follow through on its so-called ‘access initiative’ leaves people unable to access a vital drug to treat a deadly co-infection for HIV. Go to Source Date: June 27, 2019 at 09:06 Author: https://www.msf.org – joanna.keenan